| Patient | Florence Nightingale |
|---|---|
| Date of birth | 1988-05-12 |
| Identifiers | MRN HR-NI004-SYN; SSN (made up) 000-04-9271 |
| Document date | 2026-03-02 |
| Author | Isobel Marchetti, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
The patient attends this visit for new patient visit for nearly three years of exhausting fatigue that worsens after exertion. [S]
Hemoglobin: 12.9 g/dL; White cell count: 5.8 10*3/uL; Platelets: 246 10*3/uL; Sodium: 139 mmol/L; Potassium: 4.2 mmol/L; Creatinine: 0.72 mg/dL; eGFR: 110 mL/min/1.73 m²; Glucose: 86 mg/dL; Calcium: 9.3 mg/dL; Albumin: 4.3 g/dL; ALT: 16 U/L; AST: 19 U/L; Alkaline phosphatase: 68 U/L; Total bilirubin: 0.6 mg/dL; Phosphate: 3.6 mg/dL; ESR: 8 mm/h; CRP: 1.2 mg/L; TSH: 1.9 mIU/L; HbA1c: 5.1%; Ferritin: 48 ng/mL; Tissue transglutaminase IgA: 1 U/mL; Creatine kinase: 92 U/L; Morning cortisol: 14.2 ug/dL; Vitamin B12: 410 pg/mL; Folate: 12.4 ng/mL; 25-hydroxyvitamin D: 17 ng/mL (low); PHQ-9: 8; GAD-7: 5; PROMIS fatigue T-score: 71; PROMIS physical function T-score: 32; Pain score (0 to 10): 4. [S]
| Date | Measure | Value | Unit | Provenance |
|---|---|---|---|---|
| 2026-03-02 | Body height | 170 | cm | S |
| 2026-03-02 | Body weight | 55 | kg | S |
| 2026-03-02 | Body mass index (BMI) [Ratio] | 19 | kg/m2 | S |
| 2026-03-02 | Systolic blood pressure | 104 | mm[Hg] | S |
| 2026-03-02 | Diastolic blood pressure | 66 | mm[Hg] | S |
| 2026-03-02 | Heart rate | 78 | /min | S |
| 2026-03-02 | Respiratory rate | 14 | /min | S |
| 2026-03-02 | Body temperature | 36.6 | Cel | S |
| 2026-03-02 | Oxygen saturation in Arterial blood by Pulse oximetry | 99 | % | S |
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
|---|---|---|---|---|---|---|
| 2026-03-02 | Hemoglobin [Mass/volume] in Blood | 12.9 | g/dL | 11.6-15 g/dL | Normal | S |
| 2026-03-02 | Leukocytes [#/volume] in Blood by Automated count | 5.8 | 10*3/uL | 3.4-10.8 10*3/uL | Normal | S |
| 2026-03-02 | Platelets [#/volume] in Blood by Automated count | 246 | 10*3/uL | 150-450 10*3/uL | Normal | S |
| 2026-03-02 | Sodium [Moles/volume] in Serum or Plasma | 139 | mmol/L | 135-145 mmol/L | Normal | S |
| 2026-03-02 | Potassium [Moles/volume] in Serum or Plasma | 4.2 | mmol/L | 3.5-5.1 mmol/L | Normal | S |
| 2026-03-02 | Creatinine [Mass/volume] in Serum or Plasma | 0.72 | mg/dL | 0.59-1.04 mg/dL | Normal | S |
| 2026-03-02 | Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M | 110 | mL/min/{1.73_m2} | >=60 mL/min/1.73 m² | Normal | S |
| 2026-03-02 | Glucose [Mass/volume] in Serum or Plasma | 86 | mg/dL | 70-99 mg/dL | Normal | S |
| 2026-03-02 | Calcium [Mass/volume] in Serum or Plasma | 9.3 | mg/dL | 8.6-10.2 mg/dL | Normal | S |
| 2026-03-02 | Albumin [Mass/volume] in Serum or Plasma | 4.3 | g/dL | 3.5-5.2 g/dL | Normal | S |
| 2026-03-02 | Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma | 16 | U/L | 7-35 U/L | Normal | S |
| 2026-03-02 | Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma | 19 | U/L | 10-35 U/L | Normal | S |
| 2026-03-02 | Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma | 68 | U/L | 44-121 U/L | Normal | S |
| 2026-03-02 | Bilirubin.total [Mass/volume] in Serum or Plasma | 0.6 | mg/dL | 0.1-1.2 mg/dL | Normal | S |
| 2026-03-02 | Phosphate [Mass/volume] in Serum or Plasma | 3.6 | mg/dL | 2.5-4.5 mg/dL | Normal | S |
| 2026-03-02 | Erythrocyte [Sedimentation Rate] in Blood by Westergren method | 8 | mm/h | <=20 mm/h | Normal | S |
| 2026-03-02 | C reactive protein [Mass/volume] in Serum or Plasma | 1.2 | mg/L | <=5 mg/L | Normal | S |
| 2026-03-02 | Thyrotropin [Units/volume] in Serum or Plasma | 1.9 | m[IU]/L | 0.45-4.5 mIU/L | Normal | S |
| 2026-03-02 | Hemoglobin A1c/Hemoglobin.total in Blood | 5.1 | % | <=5.6% | Normal | S |
| 2026-03-02 | Ferritin [Mass/volume] in Serum or Plasma | 48 | ng/mL | 30-150 ng/mL | Normal | S |
| 2026-03-02 | Tissue transglutaminase IgA Ab [Units/volume] in Serum | 1 | U/mL | <=3.9 U/mL | Normal | S |
| 2026-03-02 | Creatine kinase [Enzymatic activity/volume] in Serum or Plasma | 92 | U/L | 26-192 U/L | Normal | S |
| 2026-03-02 | Cortisol [Mass/volume] in Serum or Plasma | 14.2 | ug/dL | 6.2-19.4 ug/dL | Normal | S |
| 2026-03-02 | Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma | 410 | pg/mL | 232-1245 pg/mL | Normal | S |
| 2026-03-02 | Folate [Mass/volume] in Serum or Plasma | 12.4 | ng/mL | >=5.9 ng/mL | Normal | S |
| 2026-03-02 | 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Mass/volume] in Serum or Plasma | 17 | ng/mL | 30-100 ng/mL | Low | S |
| 2026-03-02 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 8 | {score} | S | ||
| 2026-03-02 | Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ] | 5 | {score} | S | ||
| 2026-03-02 | PROMIS fatigue - version 1.0 Tscore | 71 | {score} | S | ||
| 2026-03-02 | PROMIS physical function - version 1.0 Tscore | 32 | {score} | S | ||
| 2026-03-02 | Pain severity - 0-10 verbal numeric rating [Score] - Reported | 4 | {score} | S |
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|---|---|---|---|---|
| Acetaminophen 500 mg oral tablet, one to two tablets by mouth every 6 hours as needed for muscle pain or headache, no more than 3 g a day | One to two tablets by mouth every 6 hours as needed; no more than 3 g a day | Oral route | 2025-11-03 | active | S |
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| Myalgic encephalomyelitis/chronic fatigue syndrome, post-infectious, moderate severity, with orthostatic intolerance; synthetic modern diagnosis by NICE and IOM criteria, linked to her documented Crimean fever and decades of illness, which are only retrospectively and disputedly read as ME/CFS | active | confirmed | G93.32 | S — Synthetic diagnosis made by clinical criteria after exclusion tests in the modern episode; the historical reading of her illness as ME/CFS remains R and disputed. |
| Personal history of brucellosis diagnosed by serology during an overseas field-hospital deployment and treated with six weeks of doxycycline and rifampin; no evidence of relapse | active | confirmed | Z86.19 | S — Synthetic history echoing the disputed retrospective interpretation of her Crimean fever as brucellosis; not a historical diagnosis. |